Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Drug Eluting Beads Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Oncozene Beads
  • 1.3.3 Quadra Sphere
  • 1.3.4 LC Beads
  • 1.3.5 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Drug Eluting Beads Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Specialized Clinics
  • 1.4.4 Research Centers
  • 1.4.5 Ambulatory Surgical Centers
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Drug Eluting Beads Market Size
  • 2.1.1 Global Drug Eluting Beads Revenue 2014-2025
  • 2.1.2 Global Drug Eluting Beads Sales 2014-2025
• 2.2 Drug Eluting Beads Growth Rate by Regions
  • 2.2.1 Global Drug Eluting Beads Sales by Regions 2014-2019
  • 2.2.2 Global Drug Eluting Beads Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Drug Eluting Beads Sales by Manufacturers
  • 3.1.1 Drug Eluting Beads Sales by Manufacturers 2014-2019
  • 3.1.2 Drug Eluting Beads Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Drug Eluting Beads Revenue by Manufacturers (2014-2019)
  • 3.2.2 Drug Eluting Beads Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Drug Eluting Beads Market Concentration Ratio (CR5 and HHI)
• 3.3 Drug Eluting Beads Price by Manufacturers
• 3.4 Key Manufacturers Drug Eluting Beads Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Drug Eluting Beads Market
• 3.6 Key Manufacturers Drug Eluting Beads Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Oncozene Beads Sales and Revenue (2014-2019)
  • 4.1.2 Quadra Sphere Sales and Revenue (2014-2019)
  • 4.1.3 LC Beads Sales and Revenue (2014-2019)
  • 4.1.4 Others Sales and Revenue (2014-2019)
• 4.2 Global Drug Eluting Beads Sales Market Share by Type
• 4.3 Global Drug Eluting Beads Revenue Market Share by Type
• 4.4 Drug Eluting Beads Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Drug Eluting Beads Sales by Application

6 United States

• 6.1 United States Drug Eluting Beads Breakdown Data by Company
• 6.2 United States Drug Eluting Beads Breakdown Data by Type
• 6.3 United States Drug Eluting Beads Breakdown Data by Application

7 European Union

• 7.1 European Union Drug Eluting Beads Breakdown Data by Company
• 7.2 European Union Drug Eluting Beads Breakdown Data by Type
• 7.3 European Union Drug Eluting Beads Breakdown Data by Application

8 China

• 8.1 China Drug Eluting Beads Breakdown Data by Company
• 8.2 China Drug Eluting Beads Breakdown Data by Type
• 8.3 China Drug Eluting Beads Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Drug Eluting Beads Breakdown Data by Company
• 9.2 Rest of World Drug Eluting Beads Breakdown Data by Type
• 9.3 Rest of World Drug Eluting Beads Breakdown Data by Application
• 9.4 Rest of World Drug Eluting Beads Breakdown Data by Countries
  • 9.4.1 Rest of World Drug Eluting Beads Sales by Countries
  • 9.4.2 Rest of World Drug Eluting Beads Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Biocompatibles
  • 10.1.1 Biocompatibles Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.1.4 Drug Eluting Beads Product Introduction
  • 10.1.5 Biocompatibles Recent Development
• 10.2 BTG International
  • 10.2.1 BTG International Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.2.4 Drug Eluting Beads Product Introduction
  • 10.2.5 BTG International Recent Development
• 10.3 Merit Medical Systems
  • 10.3.1 Merit Medical Systems Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.3.4 Drug Eluting Beads Product Introduction
  • 10.3.5 Merit Medical Systems Recent Development
• 10.4 CeloNova BioSciences
  • 10.4.1 CeloNova BioSciences Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.4.4 Drug Eluting Beads Product Introduction
  • 10.4.5 CeloNova BioSciences Recent Development
• 10.5 ABK Biomedical
  • 10.5.1 ABK Biomedical Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.5.4 Drug Eluting Beads Product Introduction
  • 10.5.5 ABK Biomedical Recent Development
• 10.6 Boston Scientific
  • 10.6.1 Boston Scientific Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.6.4 Drug Eluting Beads Product Introduction
  • 10.6.5 Boston Scientific Recent Development
• 10.7 Medtronic
  • 10.7.1 Medtronic Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.7.4 Drug Eluting Beads Product Introduction
  • 10.7.5 Medtronic Recent Development
• 10.8 Merit Medical Systems
  • 10.8.1 Merit Medical Systems Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.8.4 Drug Eluting Beads Product Introduction
  • 10.8.5 Merit Medical Systems Recent Development
• 10.9 Surefire Medical
  • 10.9.1 Surefire Medical Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.9.4 Drug Eluting Beads Product Introduction
  • 10.9.5 Surefire Medical Recent Development
• 10.10 Terumo
  • 10.10.1 Terumo Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Drug Eluting Beads
  • 10.10.4 Drug Eluting Beads Product Introduction
  • 10.10.5 Terumo Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Drug Eluting Beads Sales Channels
  • 11.2.2 Drug Eluting Beads Distributors
• 11.3 Drug Eluting Beads Customers

12 Market Forecast

• 12.1 Global Drug Eluting Beads Sales and Revenue Forecast 2019-2025
• 12.2 Global Drug Eluting Beads Sales Forecast by Type
• 12.3 Global Drug Eluting Beads Sales Forecast by Application
• 12.4 Drug Eluting Beads Forecast by Regions
  • 12.4.1 Global Drug Eluting Beads Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Drug Eluting Beads Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.
In 2019, the market size of Drug Eluting Beads is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug Eluting Beads.

This report studies the global market size of Drug Eluting Beads, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug Eluting Beads sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo

Market Segment by Product Type
Oncozene Beads
Quadra Sphere
LC Beads
Others

Market Segment by Application
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Drug Eluting Beads status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug Eluting Beads manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Drug Eluting Beads are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025